The case of a 7-year-old boy who suffered a convulsion during parenter
al infusion of naftidrofuryl is reported. The effectiveness of adding
naftidrofuryl to infusions designed to increase cochlear blood flow in
cases of sudden hearing loss has been keenly debated in the otologic
literature. Several hazards are associated with this drug, especially
when the infusion is performed too fast. We recommend an individual de
cision for each patient suffering from cochleo-vestibular disorder bas
ed on the neurological and cardiological risk factors and the therapeu
tic possibilities.